Fair Value Calculator Fair Value Calculator
EN DE

ARYAMAN (ARYAMAN) Fair Value & Analysis

IN · Market cap ₹7.3B

A ARYAMAN ARYAMAN · BSE
Price₹592.80
Fair Value₹431.37
Upside-27.2%
Quality57/100
Watch ARYAMAN for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹321.04 – ₹541.71

Fair value as of: Jul 5, 2026

From 24 valuation models · updated yesterday

Share price −1.0% over the past month.

Price vs Fair Value (12 months)

₹1,083 ₹581.00 Fair Value ₹431.37 Jul 2025 Jul 2026

12‑month range ₹581.00 – ₹1,083 · fair‑value band ₹321.04 – ₹541.71 · the ₹592.80 price screens above the ₹431.37 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

ARYAMAN (ARYAMAN) currently trades at ₹592.80, while our model-based Fair Value estimate is ₹431.37 — implying the stock looks roughly 27.2% overvalued today. We read business quality at 57/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, ARYAMAN generated revenue of ₹844M at a net margin of 35.0%. Revenue declined 71.5% year over year. It earns a return on equity of 19.0%. Net debt stands at ₹122M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹321.04 (bear case) to ₹541.71 (bull case); at ₹592.80, the current price sits above that range. The share trades about 46% below its 52-week high and 24% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹844M
Revenue growth (YoY) -71.5%
Net margin 35.0%
Return on equity 19.0%
Free cash flow ₹332M FY2025
P/E ratio 19.0
More key figures
Operating margin 52.2%
EPS (TTM) ₹31.12
EPS growth (YoY) -47.8%
Net debt ₹122M FY2024

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

ARYAMAN reported revenue of ₹782M in FY2025 versus ₹839M in FY2021, a compound −1.7%/yr. Reported net income was ₹296M in FY2025, compounding +58.7%/yr from FY2021.

Revenue −1.7%/yr
FY21 ₹839M
FY22 ₹535M
FY23 ₹661M
FY24 ₹1.1B
FY25 ₹782M
Net income +58.7%/yr
FY21 ₹46.6M
FY22 ₹39.2M
FY23 ₹176M
FY24 ₹316M
FY25 ₹296M

Is ARYAMAN fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "ARYAMAN Fair Value". https://www.fairvalue-calculator.com/stock/ARYAMAN

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is ARYAMAN (ARYAMAN) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹431.37 versus a price of ₹592.80 — about −27% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ARYAMAN?
Our model-based fair value for ARYAMAN is ₹431.37 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹592.80.
What is the quality score of ARYAMAN?
ARYAMAN has a Quality Score of 57/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of ARYAMAN (ARYAMAN)?
ARYAMAN reported trailing-twelve-month revenue of about ₹844M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of ARYAMAN?
The net profit margin of ARYAMAN is about 35.0%, meaning it keeps roughly 35.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.